Biomarkers for Early Detection of Malignant Mesothelioma: Diagnostic and Therapeutic Application

Cancers

Marco Tomasetti¹ 

关键词: biomarkers;    malignant meosthelioma;    asbestos exposure;    early diagnosis;   

DOI  :  10.3390/cancers2020523

来源: mdpi

【 摘 要 】

Malignant mesothelioma (MM) is a rare and aggressive tumour of the serosal cavities linked to asbestos exposure. Improved detection methods for diagnosing this type of neoplastic disease are essential for an early and reliable diagnosis and treatment. Thus, focus has been placed on finding tumour markers for the non-invasive detection of MM. Recently, some blood biomarkers have been described as potential indicators of early and advanced MM cancers. The identification of tumour biomarkers alone or in combination could greatly facilitate the surveillance procedure for cohorts of subjects exposed to asbestos, a common phenomenon in several areas of western countries.

【 授权许可】

CC BY   
© 2010 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland.